Name: UMIN ID:
Unique ID issued by UMIN | UMIN000025856 |
---|---|
Receipt number | R000029698 |
Scientific Title | Phase 1 study to evaluate the safety of dasatinib in relapsed and refractory angioimmunoblastic T-cell lymphoma |
Date of disclosure of the study information | 2017/01/30 |
Last modified on | 2018/07/31 13:07:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/01/26 13:59:52 | ||
2 | Update | 2017/07/14 16:55:11 | Recruitment status |
|
3 | Update | 2018/07/31 13:07:42 | Recruitment status Anticipated trial start date Last follow-up date |